Scarica l'app Stockscreener
7.70
0.39%
0.03
Precedente Chiudi:
$7.67
Aprire:
$7.72
Volume 24 ore:
115.39K
Relative Volume:
0.70
Capitalizzazione di mercato:
$208.95M
Reddito:
$56.13M
Utile/perdita netta:
$-14.67M
Rapporto P/E:
-10.41
EPS:
-0.74
Flusso di cassa netto:
$-9.13M
1 W Prestazione:
-6.10%
1M Prestazione:
-2.41%
6M Prestazione:
+13.57%
1 anno Prestazione:
+51.28%
Intervallo 1D:
$7.55
$7.80
Intervallo di 1 settimana:
$7.515
$8.53
Portata 52W:
$3.535
$9.40
Journey Medical Corp Stock (DERM) Company Profile
Nome
Journey Medical Corp
Settore
Telefono
480-434-6670
Indirizzo
9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Confronta DERM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DERM
Journey Medical Corp
|
7.70 | 208.13M | 56.13M | -14.67M | -9.13M | -0.74 |
|
ZTS
Zoetis Inc
|
120.98 | 52.29B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.61 | 45.27B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 42.39B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
30.13 | 34.18B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
500.30 | 21.27B | 3.08B | 1.24B | 1.07B | 25.61 |
Journey Medical Corp Stock (DERM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-25 | Iniziato | H.C. Wainwright | Buy |
| 2025-07-30 | Ripresa | B. Riley Securities | Buy |
| 2024-08-22 | Iniziato | Rodman & Renshaw | Buy |
| 2024-06-28 | Ripresa | ROTH MKM | Buy |
| 2021-12-07 | Iniziato | B. Riley Securities | Buy |
Journey Medical Corp Borsa (DERM) Ultime notizie
Layoff Tracker: Pfizer, Geron Downsize To Streamline Costs - BioSpace
Our Products | Full Products and Solutions List | Abbott U.S. - Abbott
Minocycline study shows no microbiome disruption after 16-week use By Investing.com - Investing.com Nigeria
Journey Medical announces results from Phase 1 trial of DFD-29 - TipRanks
Minocycline study shows no microbiome disruption after 16-week use - Investing.com India
Journey Medical Corporation Reports Positive Phase 1 Trial Results for Emrosi, Meeting All Primary Objectives with No Safety Issues - Quiver Quantitative
Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi™ (DFD-29) on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology - Yahoo Finance
Aleen Inc. Introduces Wellness AI: A Journey into Self-Discovery, Not Medical Diagnosis - TradingView
DERM Stock On The Rise: Worth Watching As Emrosi Adoption Expands - RTTNews
Journey Medical (DERM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Price Action: Why Omega Healthcare Investors Inc. stock attracts high net worth investors2025 Technical Patterns & Free Expert Verified Stock Movement Alerts - moha.gov.vn
Journey Medical Corporation (NASDAQ:DERM) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Published on: 2025-11-27 22:02:05 - moha.gov.vn
Aug Mood: Will Franco Nevada Corporation (3FO) stock outperform global peers2025 Momentum Check & Real-Time Buy Signal Alerts - BỘ NỘI VỤ
Journey Strategic Wealth LLC Takes $250,000 Position in HCA Healthcare, Inc. $HCA - MarketBeat
VITAS Healthcare (CHE) shares caregiver Stacy Noland's hospice-at-home story in new video - Stock Titan
Journey Strategic Wealth LLC Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
Envestnet Asset Management Inc. Decreases Holdings in Journey Medical Corporation $DERM - MarketBeat
Journey Medical Corp. Experiences Revision in Stock Score Amid Mixed Financial Indicators - Markets Mojo
Head-To-Head Comparison: Dyne Therapeutics (NASDAQ:DYN) versus Journey Medical (NASDAQ:DERM) - Defense World
Analysts Are Bullish on These Healthcare Stocks: Nano-X Imaging (NNOX), Exact Sciences (EXAS) - The Globe and Mail
Will Journey Medical Corporation stock outperform international peersQuarterly Earnings Summary & Stepwise Trade Execution Plans - newser.com
Will Journey Medical Corporation stock see insider buyingMarket Growth Report & Low Volatility Stock Recommendations - newser.com
What Makes Journey Medical Corporation (DERM) a Good Investment? - Yahoo! Finance Canada
Detecting price anomalies in Journey Medical Corporation with AIEarnings Trend Report & Stepwise Entry and Exit Trade Signals - newser.com
Fourteen new option listings on November 12th - MSN
HC Wainwright Forecasts Journey Medical FY2025 Earnings - Defense World
Journey Medical Corp (DERM) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Fortress Biotech reports NDA resubmission for Menkes disease treatment - Investing.com
FY2025 EPS Estimates for Journey Medical Reduced by B. Riley - MarketBeat
FY2025 EPS Forecast for Journey Medical Decreased by Analyst - MarketBeat
Is Journey Medical Corporation forming a reversal patternFed Meeting & Low Drawdown Trading Strategies - newser.com
FY2029 EPS Estimates for Journey Medical Boosted by Analyst - Defense World
What valuation multiples suggest for Journey Medical Corporation stockPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
Can Journey Medical Corporation stock deliver sustainable ROEQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
B. Riley Increases Earnings Estimates for Journey Medical - MarketBeat
HC Wainwright Forecasts Weaker Earnings for Journey Medical - MarketBeat
Can Journey Medical Corporation stock attract ESG capital inflowsTrade Exit Summary & Daily Growth Stock Tips - newser.com
Journey Medical Corp. Hits New 52-Week High of $9.40 - Markets Mojo
Journey Medical Corporation (NASDAQ:DERM) Q3 2025 Earnings Call Transcript - Insider Monkey
Wall Street analysts’ outlook for Journey Medical Corp (DERM) - Setenews
Fortress Biotech, Inc. (NASDAQ:FBIO) Q3 2025 Earnings Call Transcript - Insider Monkey
Journey Medical (NASDAQ:DERM) Issues Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates - MSN
Journey Medical price target raised to $16 from $10 at Alliance Global - TipRanks
Buy Rating for Journey Medical Corp Driven by Emrosi’s Market Success and Growth Potential - TipRanks
Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Journey Medical Q3 2025 Earnings Call Transcript - MarketBeat
Journey Medical reports Q3 EPS (9c), consensus (4c) - TipRanks
Journey Medical earnings missed by $0.06, revenue fell short of estimates - Investing.com Canada
Journey Medical Corp Azioni (DERM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.98%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):